期刊
EUROPEAN JOURNAL OF PEDIATRICS
卷 162, 期 -, 页码 S67-S76出版社
SPRINGER
DOI: 10.1007/s00431-003-1356-y
关键词
high risk screening; inherited metabolic disease; mass spectrometry; newborn screening
类别
Gas chromatography/mass spectrometry became available more than 30 years ago and has subsequently profoundly contributed not only in the identification of a wide range of inborn errors but also as a key tool for clinical diagnostic screening of genetic metabolic disease. Due to extraordinary advances in liquid chromatography and mass spectrometry (MS) developed in the last decade, the utilisation of MS and the potential number of applications for the purpose of metabolic screening is currently undergoing considerable expansion. Conclusion: This overview aims to describe only current new developments in clinically most relevant applications, in particular with focus on low molecular weight compounds.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据